-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SCT-200 in Esophageal Squamous Cell Carcinoma (ESCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SCT-200 in Esophageal Squamous Cell Carcinoma (ESCC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SCT-200 in Esophageal Squamous Cell Carcinoma (ESCC) Drug Details:...
-
Product Insights
NewEbolavirus Infections (Ebola Hemorrhagic Fever) – Drugs In Development, 2024
Empower your strategies with our Ebolavirus Infections (Ebola Hemorrhagic Fever) – Drugs In Development, 2024 report and make more profitable business decisions. Ebola is a rare but deadly viral infection that causes bleeding inside and outside the body. Signs and symptoms include fever, severe headache, joint and muscle aches, sore throat, nausea and vomiting, diarrhea, chest pain, and cough. Supportive therapy includes oxygen therapy, blood transfusions, intravenous fluids, and pain relievers. The Ebolavirus Infections (Ebola Hemorrhagic Fever) drugs in development market...
-
Product Insights
NewHuman Papillomavirus Infections – Drugs In Development, 2024
Empower your strategies with our Human Papillomavirus Infections – Drugs In Development, 2024 report and make more profitable business decisions. Human Papillomavirus (HPV) infections are common sexually transmitted infections caused by the HPV virus. There exist over 100 types, some leading to genital warts, while others increase the risk of various cancers, including cervical, anal, and throat cancers. Often asymptomatic, HPV can spread through sexual contact, including skin-to-skin contact. Vaccines effectively prevent many high-risk HPV types, reducing infection and cancer risk....
-
Product Insights
NewMiddle East Respiratory Syndrome (MERS) – Drugs In Development, 2024
Empower your strategies with our Middle East Respiratory Syndrome (MERS) – Drugs In Development, 2024 report and make more profitable business decisions. Middle East respiratory syndrome (MERS) is a viral respiratory disease caused by a coronavirus (MERS-CoV). Symptoms include fever, cough, and shortness of breath. Other symptoms include nausea, vomiting, and diarrhea. Pneumonia is common, and organs damage can occur to the kidneys or other organs. Treatment is aimed at relieving symptoms (joint pain and fever) with fluids and medications. The...
-
Product Insights
NewAvian Influenza – Drugs In Development, 2024
Empower your strategies with our Avian Influenza – Drugs In Development, 2024 report and make more profitable business decisions. Avian influenza, commonly referred to as bird flu, is a viral infection that primarily affects birds, especially poultry such as chickens and turkeys. Various strains of avian influenza viruses exist, some of which can cause severe illness in birds and, in certain cases, pose a risk to human health. Avian influenza viruses belong to the influenza A virus family and are classified...
-
Product Insights
NewChronic Fatigue Syndrome (Myalgic Encephalomyelitis) – Drugs In Development, 2024
Empower your strategies with our Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) – Drugs In Development, 2024 report and make more profitable business decisions. Chronic Fatigue Syndrome (CFS) or Myalgic Encephalomyelitis (ME) is a chronic condition causing fatigue and malaise which worsens with underlying diseases of cognitive dysfunction, immune dysfunction, unrefreshing sleep, pain, autonomic dysfunction, neuroendocrine and immune symptoms. The cause of this condition is unpredictable, but the symptoms can vary and are unpredictable. Fatigue or tiredness, extreme pain or discomfort, insomnia or...
-
Product Insights
NewInfluenza A Virus, H7N9 Subtype Infections – Drugs In Development, 2024
Empower your strategies with our Influenza A Virus, H7N9 Subtype Infections – Drugs In Development, 2024 report and make more profitable business decisions. Avian influenza A (H7N9) is a subtype of influenza viruses known as "bird flu". This infection is seen both in humans and birds. Infection is caused when a person is exposure to infected poultry or contaminated environments. Symptoms include fever, cough that produces sputum, headache, myalgia, and general malaise. Treatment includes antiviral drugs. The Influenza A Virus, H7N9...
-
Product Insights
NewEncephalomyelitis – Drugs In Development, 2024
Empower your strategies with our Encephalomyelitis – Drugs In Development, 2024 report and make more profitable business decisions. Encephalomyelitis is an inflammation of the brain and spinal cord. Encephalomyelitis can be caused by a variety of conditions that lead to irritation of the brain and spinal cord. Among the common causes of encephalomyelitis are viruses which infect the nervous tissues. Signs and symptoms include neck stiffness, headache, and fever. Treatment includes antibiotics and corticosteroids. The Encephalomyelitis drugs in development market research...
-
Product Insights
NewTransitional Cell Carcinoma (Urothelial Cell Carcinoma) – Drugs In Development, 2024
Empower your strategies with our Transitional Cell Carcinoma (Urothelial Cell Carcinoma) – Drugs In Development, 2024 report and make more profitable business decisions. Transitional cell carcinoma (TCC), also known asurothelial cell carcinoma, is a type of cancer that primarily affects the transitional epithelial cells lining the urinary tract, including the bladder, ureters, and renal pelvis. It is the most common form of bladder cancer. TCC arises when these cells undergo malignant changes, often due to exposure to carcinogens like tobacco or...